This inventor holds 2 USPTO granted patents. Top assignee: Fe Rx Incorporated. Active years: 2001-2002.
Location History:
- Moscow, RU (2001)
- Mosow, RU (2002)
Company Filing History:
Years Active: 2001-2002
Title: Innovations of Sergi V Chernyakov
Introduction
Sergi V Chernyakov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of magnetically responsive compositions. With a total of 2 patents, his work focuses on innovative methods for carrying biologically active substances.
Latest Patents
Chernyakov's latest patents include a magnetically responsive composition that features a ferrocarbon particle composition. This composition is designed for magnetically controllable applications and can carry biologically active substances. The particles range in size from 0.1 to 5.0 µm, with a preferred size between 0.5 and 5.0 µm. The composition consists of 1.0 to 95.0% by mass of carbon, ideally between 20% and 60%. The production process involves mechanical milling of iron and carbon powders, followed by the optional adsorption of biologically active substances onto the particles. Another patent focuses on a carrier composition that transports biologically active substances to treatment zones in the body under magnetic control. This composition also comprises composite particles of 0.2 to 5.0 µm in size, containing similar carbon mass percentages. The particles are produced in a similar manner and are administered in suspension.
Career Highlights
Chernyakov is associated with Fe Rx Incorporated, where he continues to develop his innovative ideas. His work has the potential to revolutionize the delivery of therapeutic agents in medical applications.
Collaborations
Some of his notable coworkers include Larry M Allen and Viktor A Volkonsky, who contribute to the collaborative efforts in his research and development projects.
Conclusion
Sergi V Chernyakov's contributions to the field of magnetically responsive compositions highlight his innovative spirit and dedication to advancing medical technology. His patents reflect a commitment to improving the delivery of biologically active substances, showcasing the potential for significant advancements in therapeutic applications.